You are here : Home > The Institute > Research Themes > Biomedical Imaging > Inumac Iseult

Imaging of Neuro Disease using High Field MR and Contrastophores

Inumac

Published on 4 December 2017

The project Inumac (Imaging of Neuro disease Using high field MR and Contrastophores) or Iseult in french, is led by French-German consortium. It is aimed at pushing the frontiers of medical imaging using high field magnetic resonance and novel contrast agents and develops a unique MRI scanner for human imaging operating at 11.7T and its applications.

The project was initiated in 2006 with an overall budget of €200 million, including €80 million in public funding. The project is structured for five years and it  involves  the University of Freiburg (Germany), Siemens Medical Solutions (Germany), Bruker BioSpin GmbH (Germany), the French Commissariat à l'énergie atomique (CEA, France), Guerbet (France) and Alstom (France).

 

3 objectives: 

  • To build a MRI system with high field (11,7T) for human. The system is planned to be installed at NeuroSpin in 2016
  • To improve the  high field magnetic resonance imaging (MRI)
  • To develop novel contrast agents (done in June 2012)

At the CEA, this project is a collaboration between:

  • NeuroSpin, carrier of the contrast agent project and 11.7T MRI project
  • The IRFU, in charge of the construction of the superconducting magnet and the MRI antenna

Strategic pilot: Denis Le Bihan
Operational pilot: Cécile Lerman